B S Lewis, A S Mitha, M S Gotsman. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, OralAdolescentAdrenergic beta-Antagonists/administration & dosageAdrenergic beta-Antagonists/adverse effectsAdrenergic beta-Antagonists/therapeutic useAdultAgedAnilides/administration & dosageAnilides/adverse effectsAnilides/therapeutic useArrhythmias, Cardiac/drug therapyChildDrug SynergismDrug Therapy, CombinationEthanolamines/administration & dosageEthanolamines/adverse effectsEthanolamines/therapeutic useHumansInjections, IntravenousMiddle AgedPhenyl Ethers/administration & dosagePhenyl Ethers/adverse effectsPhenyl Ethers/therapeutic usePropylamines/administration & dosagePropylamines/adverse effectsPropylamines/therapeutic useQuinidine/therapeutic use
Substances： See more » Adrenergic beta-AntagonistsAnilidesEthanolaminesPhenyl EthersPropylaminesQuinidine
Year: 1974 PMID： 4150954
Source DB: PubMed Journal: S Afr Med J